ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells

Nucleic Acids Research

Volumn 42, Issue 19, 2014, Pages 11928-11940

  Plotnik, Joshua P ^a   Budka, Justin A ^b   Ferris, Mary W ^b   Hollenhorst, Peter C ^b  

^a INDIANA UNIVERSITY   (United States)

^b Indiana University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1; PROTEIN P21; TRANSCRIPTION FACTOR ETS;

ARTICLE; BINDING SITE; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DUSP4 GENE; DUSP6 GENE; EPITHELIUM CELL; GENE; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRY4 GENE; TRANSCRIPTION INITIATION; CACO 2 CELL LINE; CARCINOMA; CELL CULTURE; CELL MOTION; ENZYMOLOGY; GENETICS; HUMAN GENOME; METABOLISM; PHYSIOLOGY; REGULATORY SEQUENCE; TUMOR CELL LINE;

BINDING SITES; CACO-2 CELLS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENOME, HUMAN; HUMANS; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENE PROTEINS P21(RAS); REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 84925283497     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku929     Document Type: Article

References (60)

1. Fernandez-Medarde, A. and Santos, E. (2011) Ras in cancer and developmental diseases. Genes Cancer, 2, 344-358.
2. Pratilas, C.A., Taylor, B.S., Ye, Q., Viale, A., Sander, C., Solit, D.B. and Rosen, N. (2009) (V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway. Proc. Natl Acad. Sci. U.S.A., 106, 4519-4524.
3. Imler, J.L., Schatz, C., Wasylyk, C., Chatton, B. and Wasylyk, B. (1988) A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum. Nature, 332, 275-278.
4. Wasylyk, B., Wasylyk, C., Flores, P., Begue, A., Leprince, D. and Stehelin, D. (1990) The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature, 346, 191-193.
5. Hollenhorst, P.C., McIntosh, L.P. and Graves, B.J. (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu. Rev. Biochem., 80, 437-471.
6. Eferl, R. and Wagner, E.F. (2003) AP-1: A double-edged sword in tumorigenesis. Nat. Rev. Cancer, 3, 859-868.
7. Gavrilov, D., Kenzior, O., Evans, M., Calaluce, R. and Folk, W.R. (2001) Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers. Eur. J. Cancer, 37, 1033-1040.
8. Gutman, A. and Wasylyk, B. (1990) The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J., 9, 2241-2246.
9. D'Orazio, D., Besser, D., Marksitzer, R., Kunz, C., Hume, D.A., Kiefer, B. and Nagamine, Y. (1997) Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene, 201, 179-187.
10. Yang, B.S., Hauser, C.A., Henkel, G., Colman, M.S., Van Beveren, C., Stacey, K.J., Hume, D.A., Maki, R.A. and Ostrowski, M.C. (1996) Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol., 16, 538-547.
11. Bosc, D.G., Goueli, B.S. and Janknecht, R. (2001) HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene, 20, 6215-6224.
12. Foulds, C.E., Nelson, M.L., Blaszczak, A.G. and Graves, B.J. (2004) Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol. Cell. Biol., 24, 10954-10964.
13. Charlot, C., Dubois-Pot, H., Serchov, T., Tourrette, Y. and Wasylyk, B. (2010) A review of post-translational modifications and subcellular localization of Ets transcription factors: Possible connection with cancer and involvement in the hypoxic response. Methods Mol. Biol., 647, 3-30.
14. Yamamoto, H., Flannery, M.L., Kupriyanov, S., Pearce, J., McKercher, S.R., Henkel, G.W., Maki, R.A., Werb, Z. and Oshima, R.G. (1998) Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev., 12, 1315-1326.
15. Kabbout, M., Dakhlallah, D., Sharma, S., Bronisz, A., Srinivasan, R., Piper, M., Marsh, C.B. and Ostrowski, M.C. (2014) MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation. PLoS One, 9, e100693.
16. Hollenhorst, P.C., Shah, A.A., Hopkins, C. and Graves, B.J. (2007) Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev., 21, 1882-1894.
17. Hollenhorst, P.C., Chandler, K.J., Poulsen, R.L., Johnson, W.E., Speck, N.A. and Graves, B.J. (2009) DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet., 5, e1000778.
18. Hollenhorst, P.C., Ferris, M.W., Hull, M.A., Chae, H., Kim, S. and Graves, B.J. (2011) Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells. Genes Dev., 25, 2147-2157.
19. Patel, M., Simon, J.M., Iglesia, M.D., Wu, S.B., McFadden, A.W., Lieb, J.D. and Davis, I.J. (2012) Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription. Genome Res., 22, 259-270.
20. Hollenhorst, P.C., Jones, D.A. and Graves, B.J. (2004) Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res., 32, 5693-5702.
21. Selvaraj, N., Budka, J.A., Jerde, T.J., Ferris, M.W. and Hollenhorst, P.C. (2014) Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation. Mol. Cancer, 13, 61.
22. Thurman, R.E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M.T., Haugen, E., Sheffield, N.C., Stergachis, A.B., Wang, H., Vernot, B. et al. (2012) The accessible chromatin landscape of the human genome. Nature, 489, 75-82.
23. Stewart, S.A., Dykxhoorn, D.M., Palliser, D., Mizuno, H., Yu, E.Y., An, D.S., Sabatini, D.M., Chen, I.S., Hahn, W.C., Sharp, P.A. et al. (2003) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA, 9, 493-501.
24. Dull, T., Zufferey, R., Kelly, M., Mandel, R.J., Nguyen, M., Trono, D. and Naldini, L. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol., 72, 8463-8471.
25. Hollenhorst, P.C., Paul, L., Ferris, M.W. and Graves, B.J. (2011) The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells. Genes Cancer, 1, 1044-1052.
26. Nix, D.A., Courdy, S.J. and Boucher, K.M. (2008) Empirical methods for controlling false positives and estimating confidence in ChIP-Seq peaks. BMC Bioinformatics, 9, 523.
27. Guo, Y., Mahony, S. and Gifford, D.K. (2012) High resolution genome wide binding event finding and motif discovery reveals transcription factor spatial binding constraints. PLoS Comput. Biol., 8, e1002638.
28. Thomas-Chollier, M., Darbo, E., Herrmann, C., Defrance, M., Thieffry, D. and van Helden, J. (2012) A complete workflow for the analysis of full-size ChIP-seq (and similar) data sets using peak-motifs. Nat. Protoc., 7, 1551-1568.
29. Trapnell, C., Hendrickson, D.G., Sauvageau, M., Goff, L., Rinn, J.L. and Pachter, L. (2013) Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol., 31, 46-53.
30. Joyce, T., Cantarella, D., Isella, C., Medico, E. and Pintzas, A. (2009) A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. Clin. Exp. Metastasis, 26, 569-587.
31. Galang, C.K., Der, C.J. and Hauser, C.A. (1994) Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene, 9, 2913-2921.
32. Wang, X.S., Shankar, S., Dhanasekaran, S.M., Ateeq, B., Sasaki, A.T., Jing, X., Robinson, D., Cao, Q., Prensner, J.R., Yocum, A.K. et al. (2011) Characterization of KRAS rearrangements in metastatic prostate cancer. Cancer Discov., 1, 35-43.
33. Brase, J.C., Johannes, M., Mannsperger, H., Falth, M., Metzger, J., Kacprzyk, L.A., Andrasiuk, T., Gade, S., Meister, M., Sirma, H. et al. (2011) TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-beta signaling. BMC Cancer, 11, 507.
34. Nelson, M.L., Kang, H.S., Lee, G.M., Blaszczak, A.G., Lau, D.K., McIntosh, L.P. and Graves, B.J. (2010) Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP. Proc. Natl Acad. Sci. USA, 107, 10026-10031.
35. Valouev, A., Johnson, D.S., Sundquist, A., Medina, C., Anton, E., Batzoglou, S., Myers, R.M. and Sidow, A. (2008) Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data. Nat. Methods, 5, 829-834.
36. Odrowaz, Z. and Sharrocks, A.D. (2012) ELK1 uses different DNA binding modes to regulate functionally distinct classes of target genes. PLoS Genet., 8, e1002694.
37. Seth, A. and Papas, T.S. (1990) The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene, 5, 1761-1767.
38. Consortium, E.P., Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C. and Snyder, M. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
39. Caunt, C.J. and Keyse, S.M. (2013) Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling. FEBS J., 280, 489-504.
40. Kurpios, N.A., MacNeil, L., Shepherd, T.G., Gludish, D.W., Giacomelli, A.O. and Hassell, J.A. (2009) The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development. Dev. Biol., 325, 106-121.
41. Eo, J., Han, K., K, M.M., Song, H. and Lim, H.J. (2008) Etv5, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2. J. Endocrinol., 198, 281-290.
42. Tyagi, G., Carnes, K., Morrow, C., Kostereva, N.V., Ekman, G.C., Meling, D.D., Hostetler, C., Griswold, M., Murphy, K.M., Hess, R.A. et al. (2009) Loss of Etv5 decreases proliferation and RET levels in neonatal mouse testicular germ cells and causes an abnormal first wave of spermatogenesis. Biol. Reprod., 81, 258-266.
43. Chen, C., Ouyang, W., Grigura, V., Zhou, Q., Carnes, K., Lim, H., Zhao, G.Q., Arber, S., Kurpios, N., Murphy, T.L. et al. (2005) ERM is required for transcriptional control of the spermatogonial stem cell niche. Nature, 436, 1030-1034.
44. Arber, S., Ladle, D.R., Lin, J.H., Frank, E. and Jessell, T.M. (2000) ETS gene Er81 controls the formation of functional connections between group Ia sensory afferents and motor neurons. Cell, 101, 485-498.
45. Livet, J., Sigrist, M., Stroebel, S., De Paola, V., Price, S.R., Henderson, C.E., Jessell, T.M. and Arber, S. (2002) ETS gene Pea3 controls the central position and terminal arborization of specific motor neuron pools. Neuron, 35, 877-892.
46. Chotteau-Lelievre, A., Montesano, R., Soriano, J., Soulie, P., Desbiens, X. and de Launoit, Y. (2003) PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. Dev. Biol., 259, 241-257.
47. Iwamoto, M., Higuchi, Y., Koyama, E., Enomoto-Iwamoto, M., Kurisu, K., Yeh, H., Abrams, W.R., Rosenbloom, J. and Pacifici, M. (2000) Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. J. Cell. Biol., 150, 27-40.
48. Loughran, S.J., Kruse, E.A., Hacking, D.F., de Graaf, C.A., Hyland, C.D., Willson, T.A., Henley, K.J., Ellis, S., Voss, A.K., Metcalf, D. et al. (2008) The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat. Immunol., 9, 810-819.
49. Taoudi, S., Bee, T., Hilton, A., Knezevic, K., Scott, J., Willson, T.A., Collin, C., Thomas, T., Voss, A.K., Kile, B.T. et al. (2011) ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification. Genes Dev., 25, 251-262.
50. Barton, K., Muthusamy, N., Fischer, C., Ting, C.N., Walunas, T.L., Lanier, L.L. and Leiden, J.M. (1998) The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity, 9, 555-563.
51. Wei, G., Srinivasan, R., Cantemir-Stone, C.Z., Sharma, S.M., Santhanam, R., Weinstein, M., Muthusamy, N., Man, A.K., Oshima, R.G., Leone, G. et al. (2009) Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood, 114, 1123-1130.
52. John, S., Russell, L., Chin, S.S., Luo, W., Oshima, R. and Garrett-Sinha, L.A. (2014) Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation. Mol. Cell. Biol., 34, 522-532.
53. Zhang, Y., Yan, L.X., Wu, Q.N., Du, Z.M., Chen, J., Liao, D.Z., Huang, M.Y., Hou, J.H., Wu, Q.L., Zeng, M.S. et al. (2011) miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res., 71, 3552-3562.
54. Nakayama, T., Ito, M., Ohtsuru, A., Naito, S. and Sekine, I. (2001) Expression of the ets-1 proto-oncogene in human colorectal carcinoma. Mod. Path., 14, 415-422.
55. Munera, J., Cecena, G., Jedlicka, P., Wankell, M. and Oshima, R.G. (2011) Ets2 regulates colonic stem cells and sensitivity to tumorigenesis. Stem Cells, 29, 430-439.
56. Sussan, T.E., Yang, A., Li, F., Ostrowski, M.C. and Reeves, R.H. (2008) Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature, 451, 73-75.
57. Czuwara-Ladykowska, J., Sementchenko, V.I., Watson, D.K. and Trojanowska, M. (2002) Ets1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J. Biol. Chem., 277, 20399-20408.
58. Nakazawa, Y., Suzuki, M., Manabe, N., Yamada, T., Kihara-Negishi, F., Sakurai, T., Tenen, D.G., Iwama, A., Mochizuki, M. and Oikawa, T. (2007) Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression. Oncogene, 26, 3541-3550.
59. Pal, M., Koul, S. and Koul, H.K. (2013) The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells. J. Biol. Chem., 288, 12222-12231.
60. Findlay, V.J., Turner, D.P., Yordy, J.S., McCarragher, B., Shriver, M.R., Szalai, G., Watson, P.M., Larue, A.C., Moussa, O. and Watson, D.K. (2011) Prostate-derived ETS factor regulates epithelial-to-mesenchymal transition through both SLUG-dependent and independent mechanisms. Genes Cancer, 2, 120-129.